Article Text
Abstract
The rapid development of widely available and effective vaccines has been integral to the international response to the COVID-19 pandemic. However, a significant minority of those offered vaccination have refused, often due to their adherence to ‘anti-vax’ beliefs. These beliefs include that vaccines are dangerous, render the recipient magnetic or contain government microchips.
During the pandemic, numerous calls were made for those voluntarily refusing vaccination to be deprioritised when allocating scarce healthcare resources. While these calls were rejected, the likelihood of the same calls being made during future pandemics necessitates a thorough examination of the ethical implications entailed by such a policy.
Here, I consider an intuitive argument for the use of vaccination status when allocating healthcare resources. This argument claims that, by avoiding vaccination, vaccine refusers are failing to fulfil a social obligation to protect those around them from harm by facilitating herd immunity. They are, therefore, less deserving of healthcare than their vaccinated peers.
I explore three objections to this argument. While a first objection, asserting that no individual can be held responsible for a failure to develop herd immunity, fails, I find two further responses, respectively asserting the primacy of patient autonomy and highlighting the harms deprioritising vaccine refusers would cause to disadvantaged minorities, compelling. I, therefore, conclude that vaccination status should not be considered during healthcare resource allocation, as such discrimination would disproportionately harm marginalised communities.
- Resource Allocation
- Policy
- Philosophy- Medical
Data availability statement
Data sharing is not applicable as no data sets were generated and/or analysed for this study.
Statistics from Altmetric.com
Data availability statement
Data sharing is not applicable as no data sets were generated and/or analysed for this study.
Footnotes
Twitter @icjb25
Contributors No other authors have contributed to the production of this document.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- COVID-19 vaccine hesitancy and vaccine passports: a cross-sectional conjoint experiment in Japan
- Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Africa: a scoping review
- Vaccine hesitancy from the parent perspectives: protocol for a qualitative study in Iran
- Assessing vaccine hesitancy in Arab countries in the Middle East and North Africa (MENA) region: a scoping review protocol
- Understanding non-vaccinating parents’ views to inform and improve clinical encounters: a qualitative study in an Australian community
- The language of vaccination campaigns during COVID-19
- Current tools available for investigating vaccine hesitancy: a scoping review protocol
- Exploring COVID-19 vaccine uptake, confidence and hesitancy among people experiencing homelessness in Toronto, Canada: protocol for the Ku-gaa-gii pimitizi-win qualitative study
- Perspectives of primary care physicians on acceptance and barriers to COVID-19 vaccination
- Spoonful of honey or a gallon of vinegar? A conditional COVID-19 vaccination policy for front-line healthcare workers